Variables | n | MPA n (%) | CA n (%) | P |
---|---|---|---|---|
Age | ||||
< 60 | 1996 | 692 (45.7) | 1304 (31.2) | 0.00 |
≥ 60 | 3693 | 823 (54.3) | 2870 (68.8) | |
Gender | ||||
Female | 1614 | 603 (39.8) | 1011 (24.2) | 0.00 |
Male | 4075 | 912 (60.2) | 3163 (75.8) | |
Race | ||||
White | 4332 | 1056 (69.7) | 3276 (78.5) | 0.00 |
Black | 593 | 192 (12.7) | 401 (9.6) | |
Others | 764 | 267 (17.6) | 497 (11.9) | |
Differentiation | ||||
Well/ Moderate | 1885 | 121 (8) | 1764 (42.3) | 0.00 |
Poor/undifferentiated | 3804 | 1394 (92) | 2410 (57.7) | |
Clinical stage | ||||
I | 1764 | 401 (26.5) | 1363 (32.7) | 0.00 |
II | 2032 | 495 (32.7) | 1537 (36.8) | |
III | 1893 | 619 (40.8) | 1274 (30.5) | |
T stage | ||||
T1 | 877 | 193 (12.7) | 684 (16.4) | 0.00 |
T2 | 3089 | 799 (52.8) | 2290 (54.9) | |
T3 | 1564 | 473 (31.2) | 1091 (26.1) | |
T4 | 159 | 50 (3.3) | 109 (2.6) | |
N stage | ||||
N0 | 1924 | 462 (30.5) | 1462 (35) | 0.00 |
N1 | 2861 | 707 (46.7) | 2154 (51.6) | |
N2 | 904 | 346 (22.8) | 558 (13.4) | |
Surgery | ||||
Yes | 4123 | 1241 (81.9) | 2882 (69.1) | 0.00 |
No | 1566 | 274 (18.1) | 1292 (30.9) | |
Chemotherapy | ||||
Yes | 5101 | 1392 (91.9) | 3709 (88.9) | 0.001 |
No/ unkown | 588 | 123 (8.1) | 465 (11.1) | |
Radiotherapy | ||||
Yes | 5533 | 1472 (97.2) | 4061 (92.3) | 0.78 |
No | 156 | 43 (2.8) | 113 (7.7) |